Furthermore, for the first time, we validated both in vitro and in vivo that PABPC4 promotes the progression of DLBCL, offering new perspectives on the underlying mechanisms of DLBCL development. The gene discussed is PABPC4; the disease is diffuse large B-cell lymphoma.